EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Stimuli-responsive nanoscale drug delivery system for epilepsy theranostics

Qi Zhang, Yi Wang, Di Wu, Zhong Chen

Acta Biomaterialia · 2025-03 · 194 · 58-79

DOI: 10.1016/j.actbio.2025.01.046 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Biomaterialia, 2025-03. Verfasst von Qi Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences and School of Basic Medical Sc…. Hauptthemen laut MEDLINE: Epilepsy, Theranostic Nanomedicine, Drug Delivery Systems, Anticonvulsants. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 223 Literaturangaben. Gefördert von: China Association for Science and Technology, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epilepsy is a common neurological disease characterized by distinct pathological changes in the epileptogenic zone. Antiseizure drugs (ASDs) are widely used as the primary treatment for epilepsy. To improve the efficiency of ASDs medication, stimuli-responsive nanoscale drug delivery systems (nanoDDSs), triggered by either endogenous or exogenous factors, have been developed and been considered as a noninvasive and spatial-temporal approach to epilepsy theranostics. In this review, we introduce the pathological variations observed in epileptic lesions such as dysregulated neurotransmitter systems, disrupted ion homeostasis, and dynamic inflammatory cytokine networks. Furthermore, we summarize the recent advances in functional nano-assemblies that could be activated by endogenous stimuli of pathological alterations or exogenous stimuli such as electricity, light, and other interventions. Finally, we discuss the remaining challenges and prospect the insight into perspective of future development in this field. In summary, this review aims to highlight the potential of stimuli-responsive nanoDDSs as precise, controllable and efficient strategies for addressing unresolved issues in epilepsy theranostics. STATEMENT OF SIGNIFICANCE: This review summarizes recent progress in pathological changes such as dysregulated neurotransmitter system, disrupted ion homeostasis and dynamic inflammatory cytokine network, and emphasizes endogenous/exogenous stimuli-responsive nanoscale platforms including neurotransmitter-, ion-, and other stimuli-responsive nanoDDSs, providing the prospects of smart nanoDDSs applications and discussing the challenges to offer generalized guideline for further development of epilepsy theranostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyTheranostic NanomedicineDrug Delivery SystemsAnticonvulsantsHumansAnimals

Stichwörter der Autor:innen

Epilepsy theranosticsNanoscale drug delivery systemPathological variationStimuli-responsive

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences and School of Basic Medical Sciences, Huzhou Central Hospital, The Fifth School of Clinical Medicine…

Förderung

  • China Association for Science and Technology
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Q., Wang, Y., Wu, D., & Chen, Z. (2025). Stimuli-responsive nanoscale drug delivery system for epilepsy theranostics. Acta Biomaterialia, 194, 58-79. https://doi.org/10.1016/j.actbio.2025.01.046

Vancouver

Zhang Q, Wang Y, Wu D, Chen Z. Stimuli-responsive nanoscale drug delivery system for epilepsy theranostics. Acta Biomaterialia. 2025;194:58-79. doi:10.1016/j.actbio.2025.01.046

BibTeX
@article{Zhang2025,
  author = {Zhang, Qi and Wang, Yi and Wu, Di and Chen, Zhong},
  title = {Stimuli-responsive nanoscale drug delivery system for epilepsy theranostics},
  journal = {Acta Biomaterialia},
  year = {2025},
  volume = {194},
  pages = {58--79},
  doi = {10.1016/j.actbio.2025.01.046}
}
Kostenlos starten →